Diagnostic Medical Systems S.A. (EPA:ALDMS)
France · Delayed Price · Currency is EUR 0.9220
+0.0140 (1.54%)
Oct 2, 2026, 5:35 PM CET
EPA:ALDMS Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 48.55 | 49.97 | 46.07 | 42.15 | 35.27 | 36.27 |
Other Revenue | 2.86 | 2.88 | 2.79 | 1.96 | 1.79 | 1.76 |
| 51.41 | 52.86 | 48.86 | 44.12 | 37.06 | 38.03 | |
Revenue Growth | 3.91% | 8.19% | 10.74% | 19.05% | -2.56% | 8.57% |
Cost of Revenue | 29.92 | 31.8 | 30.32 | 28.1 | 23.02 | 24.32 |
Gross Profit | 21.49 | 21.06 | 18.54 | 16.01 | 14.04 | 13.71 |
Selling, General & Admin | 16 | 16.41 | 15.75 | 13.91 | 11.87 | 12.14 |
Amortization of Goodwill & Intangibles | 1.4 | 1.48 | 1.74 | 1.56 | 1.44 | 1.16 |
Other Operating Expenses | 1.33 | 1.12 | 1 | 1.48 | 6.9 | 0.47 |
Operating Expenses | 19.55 | 19.89 | 19.33 | 17.73 | 20.9 | 14.54 |
Operating Income | 1.94 | 1.16 | -0.79 | -1.71 | -6.86 | -0.83 |
Interest Expense | -0.72 | -0.76 | -0.74 | -0.46 | -0.22 | -0.3 |
Currency Exchange Gain (Loss) | 0 | 0.09 | 0.12 | -0.19 | 0.01 | 0 |
Other Non Operating Income (Expenses) | -0.28 | -0.39 | -1.65 | -6.93 | -0.55 | -0.13 |
EBT Excluding Unusual Items | 0.93 | 0.1 | -3.05 | -9.28 | -7.62 | -1.26 |
Merger & Restructuring Charges | - | - | - | -0.8 | - | -1.39 |
Impairment of Goodwill | - | - | - | - | -0.89 | - |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 0.16 |
Gain (Loss) on Sale of Assets | - | - | 1.13 | - | 2.29 | -0.11 |
Asset Writedown | 0 | 0.02 | 0.04 | 0.25 | - | - |
Other Unusual Items | - | - | -0.72 | - | -0.41 | - |
Pretax Income | 0.94 | 0.12 | -2.61 | -9.83 | -6.64 | -2.59 |
Income Tax Expense | 0.14 | 0.07 | 0.21 | 0 | 0.02 | - |
Earnings From Continuing Operations | 0.8 | 0.05 | -2.82 | -9.84 | -6.66 | -2.59 |
Earnings From Discontinued Operations | -0.12 | - | - | 4.82 | -2.31 | -2.13 |
Net Income to Company | 0.67 | 0.05 | -2.82 | -5.02 | -8.97 | -4.72 |
Minority Interest in Earnings | -0.23 | -0.22 | -0.06 | 0.07 | 2.15 | 0.85 |
Net Income | 0.45 | -0.17 | -2.88 | -4.95 | -6.82 | -3.88 |
Net Income to Common | 0.45 | -0.17 | -2.88 | -4.95 | -6.82 | -3.88 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 28 | 25 | 20 | 17 | 16 | 16 |
Shares Outstanding (Diluted) | 28 | 25 | 20 | 17 | 16 | 16 |
Shares Change | 21.93% | 20.91% | 17.09% | 8.33% | - | - |
EPS (Basic) | 0.02 | -0.01 | -0.14 | -0.28 | -0.42 | -0.24 |
EPS (Diluted) | 0.02 | -0.01 | -0.14 | -0.28 | -0.42 | -0.24 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4.53 | -2.42 | 0.03 | -4.37 | -4.23 | -6.96 |
Free Cash Flow Per Share | -0.16 | -0.10 | 0.00 | -0.25 | -0.26 | -0.43 |
Gross Margin | 41.79% | 39.84% | 37.95% | 36.30% | 37.89% | 36.06% |
Operating Margin | 3.77% | 2.20% | -1.61% | -3.89% | -18.51% | -2.18% |
Profit Margin | 0.87% | -0.32% | -5.90% | -11.21% | -18.40% | -10.19% |
Free Cash Flow Margin | -8.80% | -4.58% | 0.06% | -9.90% | -11.42% | -18.31% |
EBITDA | 1.24 | 1.49 | 1.79 | 0.63 | -3.39 | 1.1 |
EBITDA Margin | 2.41% | 2.83% | 3.66% | 1.42% | -9.15% | 2.90% |
D&A For EBITDA | -0.7 | 0.33 | 2.57 | 2.34 | 3.47 | 1.93 |
EBIT | 1.94 | 1.16 | -0.79 | -1.71 | -6.86 | -0.83 |
EBIT Margin | 3.77% | 2.20% | -1.61% | -3.89% | -18.51% | -2.18% |
Effective Tax Rate | 15.25% | 60.66% | - | - | - | - |